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Detection and Mutation Screening of malassezia sympodialis
Sequences Coding for the Mal s 1 Allergen Implicated in
Atopic Dermatitis
To the Editor:
Malassezia yeasts are implicated in atopic dermatitis pathogenesis
through production of IgE antibodies that recognize proteins of
Malassezia sympodialis extract in atopic patients ( Johansson and
Karlstr˛m, 1991). In these patients, skin prick and patch tests are
positive to recombinant Malassezia allergens related to T cells
with T helper 2-like cytokine pro¢le ( Johansson et al, 2002).
Schmidt et al (1997) sequenced and expressed the 1176 bp cDNA
encoding for the 37 kDaM. sympodialis ATCC 421321major aller-
genic protein Mal s 1.2 The genus Malassezia, which originally
included M. furfur, M. pachydermatis, and M. sympodialis, has only
recently been expanded to include M. globosa, M. obtusa, M. sloof-
¢ae, and M. restricta (GueŁ ho et al, 1996). Therefore, molecular
screening methods for Malassezia allergen coding sequences have
not yet been developed.
A polymerase chain reaction^single strand conformation poly-
morphism (PCR^SSCP)-based system for detecting and screen-
ingMal s 1 sequences coding for peptides rendering the allergenic
protein functional is reported herein for the ¢rst time. The meth-
od has been assessed using 36 strains comprising: 6M. furfur (CBS
6001, CBS 7019, IP 1363-82, 3 clinical strains CS); 14 M. sympodia-
lis (ATCC 42132, CBS 7222, GM 301, GM 310, 10 CS); 2M. obtusa
(CBS 7876 and GM 211); 4 M. restricta (CBS 7877, 3 CS); three M.
sloo⁄ae (CBS 7956, 2 CS); 3 M. pachydermatis (CBS 1879, ED 206,
dog otitis); and 4M. globosa (CBS 7966, 3 CS).The icosameric primers,
forward Mal s 1a (50 -AACTTGACGCCGGAGGACAC-30) and
reverse Mal s 1b (50 -ATGGCGTAGGG- GGCGCGAGC-30) (In-
teractiva Biotechnologie GmbH, Ulm, Germany) were designed
from the Mal s 1 cDNA (GenBank accession no. X96486) to am-
plify sequences coding for peptides 2, 3, 5, 7, and 9 of the func-
tional protein. Primer interactions were controlled by BLAST
(GenBank, www.ncbi.nih.gov/gebank/index.html).
Genomic DNA was prepared from pure cultures as described
previously (Gaitanis et al, 2002).The 100 mL optimized PCR reac-
tion mixture contained 5 mL PCR bu¡er (500 mM KCl, 100 mM
Tris^HCl, 15 mM MgCl2, 50 mg gelatin), 0.2 M 2-pyrrolidone
(Sigma-Aldrich, St Louis, Missouri), to exclude ampli¢cation of
atypical products (Chakrabati and Schutt, 2001), 100 pmol of each
primer, 20 mM of each deoxyribonucleoside triphosphate (Clon-
tech, Palo Alto, California), 1.2 U of Taq polymerase (Promega,
Madison,Wisconsin), and 400 ng template DNA.The PCR reac-
tions were performed in a computer-controlled robocycler (Gra-
dient 40, Stratagene, La Jolla, California) with heated lid, without
mineral oil, at an initial denaturation cycle (5 min at 941C), fol-
lowed by 38 cycles of 1min at 941C, 1min at 611C (for achieving
high stringency conditions), and 2 min at 721C, and a ¢nal exten-
sion step of 5 min at 721C.
OnlyM. sympodialis template DNA generated the expected 740
bp amplicon visualized in ethidium bromide-stained 2% agarose
gels run for 1 h at 60 V. As these sequences refer to the translated
region of the protein, it can be acknowledged that absence of a
speci¢c PCR product in all other strains of the Malassezia species
tested denotes lack of the functional protein.This is in accordance
with current observations showing thatM. globosa andM. restricta,
despite possessing numerous IgE-binding components, lack M.
sympodialis IgE-binding allergens (Zargari et al, 2003). IgE sensiti-
zation in atopic patients was lower when the M. furfur CBS 1878
extract was used, compared with that of M. sympodialis ATCC
42132 or with commercial extracts (m70 ImmunoCAP, Pharma-
cia, Diagnostic AB, Uppsala, Sweden) (Mayser and Gross, 2000).
Moreover, the involvement of M. sympodialis allergens in atopic
dermatitis aetiopathology was recently demonstrated, because
condition severity was associated with M. sympodialis reactivity
when ImmunoCAP and recombinant Mal s allergen mix were
compared ( Johansson et al, 2003). Thus, the issue of Malassezia-
induced hypersensitivity in atopic patients could have been
previously overlooked.
To test whether Mal s 1 ampli¢ed sequences re£ect a homoge-
neous M. sympodialis population structure in the cohort tested, all
PCR products were screened for mutations by SSCP analysis. For
maximum resolution of single-stranded DNA bands the 740 bp
product was digested (Gaitanis et al, 2002) with AluI (Fig 1). For
SSCP, 12 mL of the 283 bp, 266 bp, and 179 bp AluI fragments
recovered from 3% low melting point agarose gels (FMC, Bio-
Products, Rockland, Maine) and puri¢ed (MBI, Fermentas,
Lithouania) were added to 27 mL loading bu¡er [95% forma-
mide, 20 mM ethylenediamine tetraacetic acid, 0.05% bromophe-
nol blue, and 0.05% xylene cyanol (all from Sigma, St Louis,
Missouri]), heated to 951C for 10 min and quenched on ice for
denaturation. Loading of the large fragments on 10% nondena-
turing polyacrylamide gel 37.5:1 and of the 179 bp on 29:1 acryla-
mide/bisacrylamide (Sigma) was followed by electrophoresis at
350 V overnight at 81C. The gel was visualized after silver nitrate
(Sigma) staining (Gathof et al, 1995) revealing no mutations in the
tested sequences (Fig 2). Mal s 1 a/b PCR product sequencing
(QIAGEN, European Oligo Production Facility, Cologne, Ger-
many) and alignment (BLAST, GenBank) of ATCC 42132, CBS
7222, GM 310, and one M. sympodialis CS, con¢rmed both the
SSCP results and Mal s 1 clonality in our strain population. Test-
ing a larger sample size can disclose if this is a geographically
con¢ned or a general phenomenon.
The proposed PCR^SSCP system detected homogeneous Mal
s 1 allergen sequences solely in M. sympodialis strains. This system
can be applied more broadly by deriving primers from M. furfur
(sensu lato) Mal f 2, 3, and 4 genes (Yasueda et al, 1998; Onishi et al,
1999) to assay reliably whether their corresponding allergen cod-
ing sequences are also homogeneously distributed in Malassezia
populations. As ImmunoCAP and atopic dermatitis studies
have been based on M. sympodialis ATCC 42132 ( Johansson and
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Karlstr˛m, 1991; Zargari et al, 1995; Johansson et al, 2003), sensu
stricto, identi¢cation of Malassezia species and evaluation of Mal s
1 population level polymorphisms, coupled with direct detection
of Mal s 1 sequences in skin scales (Gaitanis et al, 2002; Gemmer
et al, 2002) are warranted.
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Figure1. Restriction map (NEBcutter V
1,0, tools.neb.com/NEBcutter/index.php3)
of the Mal s 1 a/b PCR product and
sequences of M. sympodialis ATCC 42132
PCR product (GenBank accession no.
AY283740). (A) Selection of Mal s 1a/b Alu I-
restriction fragments for SSCP was based on
the restriction map generated from the pub-
lished M. sympodialis ATCC 42132 sequence
(accession No. X96486). (B) Comparison and
alignment of the 740 bp PCR ampli¢ed nu-
cleotide sequences (GenBank accession Nos
AY283740^AY283743) with the published
cDNA sequence, demonstrated 100% identity
and the absence of introns in the ampli¢ed
gene region.
Figure 2. Identical AluI Mal s 1 a/b SSCP pro¢les of the 14 M. sym-
podialis type, reference, and clinical strains. (A) SSCP pro¢les of the
283 bp and 266 bp restriction fragments. (B) SSCP pro¢les of the 179 bp
restriction fragments. The 179 bp fragment codes for functional peptides 2,
3, 5, and the 266 bp fragment for peptides 7 and 9.
1560 LETTERTO THE EDITOR THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
